ArticleAdvances in experimental medicine and biology2022
Graphene-Based Materials for Efficient Neurogenesis.
Article in Advances in experimental medicine and biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The gut microbiome meets nanomaterials: exposure and interplay with graphene nanoparticles.Nanoscale advances · 2023Review
- The mechanical, optical, and thermal properties of graphene influencing its pre-clinical use in treating neurological diseases.Frontiers in neuroscience · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Graphene, a two-dimensional plane-structured carbon allotrope, has outstanding properties. Owing to their unique features, graphene-based materials including graphene derivatives have recently emerged as an ideal material and been used in various fields. Especially, in terms of specific advantages of graphene including great electrical conductivity, high potential to conjugate with biomolecules, and applicability to three-dimensional structures, neurogenesis-based stem cell therapies using graphene-based materials have been reported to be a candidate of treatment for neurodegenerative disease (e.g., Parkinson's disease, Alzheimer's disease, and Huntington's disease). To date, extensive studies on neurogenesis-based stem cell therapies including enhanced neural differentiation and monitoring stem cells behavior have been conducted using graphene-based materials. Herein, we have summarized recent various studies of neurogenesis using graphene-based materials in depth and focused on effect of graphene on functional improvement of neural stem cells and monitoring of differentiation into neural linages.
Indexed as
Identifiers
35175611What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.